International Fuel Technology Receives Its Largest Order To Date For Its PerfoLiFTTM BD-Series
ST. LOUIS, February 14, 2012 – International Fuel Technology, Inc. (IFT) (OTCBB:IFUE) announced today that a European-based bio-diesel production division of Cargill has made a significant purchase of PerfoLiFT™ BD-3, one of IFT’s PerfoLiFT™ BD-Series of fuel additives. These formulations provide superior oxidation stability and deposit formation control to bio-diesel of all underlying sources. The order came through IFT distribution partner Nordmann Rassmann Germany (NRC).
Axel Farhi, IFT’s Director of New Business Development, commenting on this major order, reiterated the key role played by IFT’s distribution partners in building sales of IFT’s breakthrough products. “This order represents the latest in a series of initial and repeat sales of the PerfoLiFT™ BD-Series to prominent bio-diesel manufactures in Europe. We are now selling PerfoLiFT™ BD-Series products to eight European-based bio-diesel manufacturers. Clearly, our distributors are successfully educating the marketplace about our products’ unique abilities.”
IFT’s PerfoLiFT™ BD-Series products have received the coveted “No Harm” certification from the German-based Association for the Quality Management of Bio-diesel (AGQM) under its “No-Harm and Efficiency” program. This certification is the international standard in the bio-diesel industry due to the demanding requirements necessary to obtain such certification and, in many countries, is necessary before entering the market.
NRC (www.nrc.de) is a prominent distributor of specialty chemicals, lubricants and fuel additives. NRC sells its portfolio of high quality products throughout Germany, Austria, Central and Eastern Europe, Scandinavia and Switzerland. IFT and NRC signed a marketing and distribution agreement in 2008 providing NRC rights to sell IFT products in fifteen major European countries.
Note
Statements contained in this web site that are not strictly historical are forward-looking within the meaning of the safe harbor clause of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that may cause the Company's actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the Company’s product both domestically and abroad, the Company's ability to continue to develop its market, general economic conditions and other factors that may be more fully described in the Company’s literature and any periodic filing with the Securities and Exchange Commission.